Meituan Unsponsored ADR MPNGY
—
18.18
(0.09)
(0.49%)
as of 25 Sep
- Market cap
- —
- P/E
- 0.0×
Follow MPNGY
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.54 | 2.55 | 1.95 | 1.61 | |
P/FCF ratio |
7.25 | 7.54 | 6.35 | 5.26 | |
P/Operating CF |
15.03 | 15.62 | 47.35 | 39.25 | |
P/B ratio |
4.98 | 4.91 | 3.83 | 3.46 | |
Price to Tangible BV |
6.03 | 5.88 | 4.58 | 4.22 | |
EV/Sales |
2.11 | 2.12 | 1.52 | 1.25 | |
EV/EBITDA |
19.36 | 17.59 | 17.52 | 0.00 | |
EV/Operating CF |
5.00 | 5.19 | 3.95 | 3.26 | |
EV/FCF |
6.02 | 6.24 | 4.93 | 4.08 | |
Quick Ratio |
1.76 | 1.90 | 1.71 | 1.42 | |
Current Ratio |
1.94 | 2.09 | 1.93 | 1.71 | |
Net Debt/EBITDA |
(21.70) | (14.68) | (694.15) | 6.61 | |
Debt/Assets |
13.05% | 12.75% | 9.64% | 10.14% | |
Debt/Equity |
0.25 | 0.23 | 0.17 | 0.19 | |
Asset Turnover |
1.09 | 1.13 | 1.17 | 1.19 | |
Operating CF/Net income |
9.17 | 0.00 | 40.80 | 0.00 | |
Capex/Depreciation |
(1.20) | — | 0.00 | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.13% | 6.67% | 6.82% | 7.26% | |
Selling, General and Administrative Expense of Revenue |
22.87% | 21.00% | 27.44% | 38.98% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.10 | |
Share Based Compensation of Revenue |
8.58% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.07 | 0.08 | 0.10 | 0.08 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(3.95%) | (3.80%) | (4.17%) | (5.03%) | |
Free Cash Flow Yield |
13.79% | 13.27% | 15.75% | 19.00% | |
Revenue per Share |
0.00 | 0.00 | 4.19 | 0.00 | |
Operating CF per Share |
0.00 | — | 0.68 | — | |
Capex per Share |
0.00 | — | (0.24) | — | |
Free Cash Flow per Share |
0.00 | — | 0.44 | — | |
Cash per Share |
0.00 | 0.00 | 8.62 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 8.40 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 8.40 | 0.00 | |
Free Cash Flow |
6,543.89 | — | 1,321.72 | — | |
Working Capital |
14,160.27 | 15,806.13 | 14,499.25 | 11,554.66 | |
Capital Expenditures |
(1,405.23) | — | (738.09) | — | |
Net Current Asset Value |
8,065.58 | 9,734.12 | 9,880.30 | 6,825.58 | |
EV/EBIT |
19.36 | 17.59 | 17.52 | 0.00 | |
Capex to Sales |
0.11 | 0.00 | 0.06 | 0.00 | |
Net Profit Margin |
7.05% | 11.62% | 0.40% | (19.51%) | |
Price to Operating Income |
23.31 | 21.23 | 22.54 | 0.00 | |
| Other line items | |||||
Average Receivables |
378.31 | 408.97 | 419.69 | 468.94 | |
Average Payables |
3,375.76 | 3,160.81 | 3,611.02 | 3,806.34 | |
Average Inventory |
212.78 | 224.23 | 269.72 | 341.04 | |
Average Assets |
43,261.43 | 42,869.72 | 42,534.50 | 42,172.36 | |
Average Common Equity |
22,740.33 | 23,598.35 | 23,817.44 | 22,877.88 |
Columns are period end dates